AM20-69: Benefit-Risk Assessment to Inform FDA Regulatory Decisions

Oct 5, 2020 ‐ Dec 31, 2022

Collection: 2020 AABB Annual Meeting On-Demand

Type: Session

Speakers:

• Dr. Hong Yang, PhD, FDA/CBER
• Dr. Richard Forshee, PhD, FDA/CBER
• Dr. Yin Huang, Food and Drug Administration

Tags: public health and policy standards regulations and accreditation recipientpatient hemovigilance - transfusion transmitted infec

AM20-45: Automated Hemovigilance: Fast Healthcare Interoperability Resources (FHIR) and Big Data Analysis

Oct 5, 2020 ‐ Dec 31, 2022

Collection: 2020 AABB Annual Meeting On-Demand

Type: Session

Speakers:

• Dr. Hamilton C. Tsang, MD, University of Washington
• Dr. Alan Williams, PhD, US FDA, Center for Biologics Evaluation and Research
• Dr. Aaron Z. Hettinger, MD, MedStar Health Research Institute

Tags: new innovations new techniques and new technologies public health and policy recipientpatient hemovigilance - noninfectious adverse events information technology it aka informatics ehr lis recipientpatient hemovigilance - transfusion transmitted infec

AM20-18: Mechanisms of Hematopoietic Stem Cells Towards Rejuvenation of the Aging Hematopoietic System

Oct 3, 2020 ‐ Dec 31, 2022

Collection: 2020 AABB Annual Meeting On-Demand

Type: Session

Speakers:

• Dr. Ross Levine, Memorial Sloan Kettering Cancer Center
• Dr. Gerald de Haan, MSc, PhD, European Research Institute for the Biology of Ageing
• Dr. Jason Butler, Hackensack Meridian Health Center

Tags: new innovations new techniques and new technologies donor testing red cells cord blood including cord tissue and perinatal cells donor hemovigilance transfusion transmitted diseases regenerative medicine somatic cell therapy recipientpatient hemovigilance - transfusion transmitted infec cell biology immunology and biochemistry basic and preclinical

AM20-10: Vector Borne Pathogens in Transfusion Medicine

Oct 3, 2020 ‐ Dec 31, 2022

Collection: 2020 AABB Annual Meeting On-Demand

Type: Session

Speakers:

• Dr. Steven Jeffrey Drews, PhD FCCM D(ABMM), Canadian Blood Services
• Dr. Silvano Wendel, MD, PhD, Hospital Sirio Libanes Blood Bank
• Dr. Evan M. Bloch, MD, Associate Professor; Associate Director, Transfusion Medicine, Johns Hopkins University School of Medicine

Tags: new innovations new techniques and new technologies donor testing quality control public health and policy donor hemovigilance transfusion transmitted diseases blood bankblood center donor collection testing processing recipientpatient hemovigilance - transfusion transmitted infec leukocytes includes experimental transplantationimmunotherapy

AM20-11: Towards Personalized Hct and HbS Targets in Transfusion for Sickle Cell Disease

Oct 3, 2020 ‐ Dec 31, 2022

Collection: 2020 AABB Annual Meeting On-Demand

Type: Session

Speakers:

• Dr. Melanie Fields, MD, St. Louis Children's Hospital
• Dr. Jon Detterich, MD, Keck School of Medicine
• Dr. David K. Wood, PhD, U of Minnesota

Tags: new innovations new techniques and new technologies hematology and coagulation transfusion medicine clinical practices patient safety red cells disorders recipientpatient hemovigilance - transfusion transmitted infec

AM20-05: Setting the Standard for Transfusion Safety: One Center's Experience Achieving Patient Based Hemovigilance

Oct 3, 2020 ‐ Dec 31, 2022

Collection: 2020 AABB Annual Meeting On-Demand

Type: Session

Speakers:

• Tonita Bates, FNP-C, MD Anderson Cancer Center
• Marah Cornelius, FNP-C, MD Anderson Cancer Center
• Leah Murphy, BSN, RN, OCN, MD Anderson Cancer Center

Tags: new innovations new techniques and new technologies transfusion medicine clinical practices operations quality management inventory management recipientpatient hemovigilance - noninfectious adverse events information technology it aka informatics ehr lis practice management recipientpatient hemovigilance - transfusion transmitted infec